SCHEMBL21595535

SCHEMBL21595535

CCOc1ccc(C(=O)Nc2cccc(Cl)c2)nc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.67
P4HTM Q9NXG6 1/20 0.58
TP53 P04637 3/20 0.57
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
GRM4 Q14833 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
NPC1 O15118 5/20 0.54
RAB9A P51151 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 3/20 0.53
MAPK1 P28482 2/20 0.53
ALDH1A1 P00352 1/20 0.53
SCN2A Q99250 1/20 0.53
SCN10A Q9Y5Y9 1/20 0.53
ALOX15 P16050 2/20 0.52
HPGD P15428 1/20 0.52
KDM4E B2RXH2 1/20 0.52
MITF O75030 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30763041 1.00 FADS1 (0.67) FADS1P4HTMTP53MEN1KMT2A
SCHEMBL21595568 0.88 FADS1 (0.52) FADS1P4HTMTP53MEN1KMT2A
SCHEMBL21601625 0.88 FADS1 (0.52) FADS1P4HTMTP53MEN1KMT2A
SCHEMBL30763253 0.88 FADS1 (0.52) FADS1P4HTMTP53MEN1KMT2A
SCHEMBL21595507 0.85 NPC1 (0.66) P4HTMTP53MEN1KMT2ANPC1
SCHEMBL28595252 0.85 P4HTM (0.58) FADS1P4HTMTP53MEN1KMT2A
SCHEMBL8136566 0.81 FADS1 (0.60) FADS1P4HTMTP53MEN1KMT2A
SCHEMBL21595592 0.81 TSHR (0.69) P4HTMTP53KMT2ANPC1RAB9A
SCHEMBL4112399 0.80 MEN1 (0.76) FADS1TP53MEN1KMT2ANPC1
SCHEMBL21595533 0.79 LMNA (0.70) P4HTMTP53KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810597-B1 1,2,4-TRIAZOLE DERIVATIVES AS TANKYRASE INHIBITORS UNIV OSLO HF (NO) 2025-11-26 EP disclosed
US-11926614-B2 1,2,4-triazole derivatives as tankyrase inhibitors OSLO UNIVERSITETSSYKEHUS HF (NO) 2024-03-12 US disclosed
EP-3810597-A1 1,2,4-TRIAZOLE DERIVATIVES AS TANKYRASE INHIBITORS Oslo Universitetssykehus HF (NO) 2021-04-28 EP disclosed
WO-2019243822-A1 1,2,4-TRIAZOLE DERIVATIVES AS TANKYRASE INHIBITORS OSLO UNIVERSITETSSYKEHUS HF (NO) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11926614-B2 1,2,4-triazole derivatives as tankyrase inhibitors GBA3, CBR3, TECR FADS1 2075/4885P4HTM 1349/4885TP53 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.